ZMapp drug fully protects monkeys against Ebola virus

Experimental treatment to fight infection finds success in animal test

ZMapp, the experimental drug recently given to six people infected with Ebola, has rescued 18 Rhesus macaque monkeys injected with the live virus.

A U.S.-Canadian research team exposed 21 monkeys to Ebola. Eighteen received a three-shot regimen of ZMapp — starting three, four or five days after infection — and survived, even though 11 had developed fever and two were starting to hemorrhage.